Skip to main content

Zai Lab Ltd (ZLAB) Stock

Zai Lab Ltd Stock Details, Movements and Public Alerts

Stock Details

Zai Lab Ltd (ZLAB), a prominent company in the healthcare sector within the biotechnology industry, is based in China and primarily trades on the NASDAQ.Currently, the stock is trading at $26.17. Over the past 52 weeks, it has ranged between $15.96 and $34.72. This places the current price at 75.4% of its 52-week high and 64.0% above its 52-week low. Recent trading volume was recorded at 705,452. The 14-day Relative Strength Index (RSI) stands at 70.36, suggesting overbought conditions. The stock is currently trading above its 50-day moving average of $20.77 by 26.00%. Similarly, it is above its 200-day moving average of $19.66 by 33.11%. The MACD histogram is 0.15, indicating bullish momentum (MACD Line: 1.78, Signal Line: 1.63). There are currently 2 active alerts set for ZLAB by users.

52-Week Range

$34.72 - $15.96

-24.63% from high · +63.97% from low

Avg Daily Volume

1,222,004

20-day average

100-day avg: 936,035

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

4.81

EV/EBITDA

-2.35

EPS (TTM)

-$1.70

Price to Sales

6.40

Beta

0.78

Less volatile than market

Q:How is ZLAB valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is ZLAB's risk profile compared to the market?
With a beta of 0.78, Zai Lab Ltd is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 4.81 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-41.90%

Operating Margin

-72.00%

EBITDA

$-248,168,000

Return on Equity

-26.90%

Return on Assets

-14.70%

Revenue Growth (YoY)

-3.30%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is ZLAB's business model?
Zai Lab Ltd achieves a profit margin of -41.90%, meaning it retains $-41.90 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -72.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -26.90% and ROA at -14.70%, the company achieves moderate returns on invested capital.
Q:What are ZLAB's recent growth trends?
Zai Lab Ltd's revenue declined by 3.30% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$2.9B

Revenue (TTM)

$449.61M

Revenue/Share (TTM)

$4.06

Shares Outstanding

112.27M

Book Value/Share

$5.96

Asset Type

Common Stock

Q:What is ZLAB's market capitalization and position?
Zai Lab Ltd has a market capitalization of $2.9B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 112.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does ZLAB's price compare to its book value?
Zai Lab Ltd's book value per share is $5.96, while the current stock price is $26.17, resulting in a price-to-book (P/B) ratio of 4.39. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$32.39

23.77% upside potential

Analyst Recommendations

Strong Buy

2

Buy

9

Hold

1

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for ZLAB?
12 analysts cover ZLAB with 92% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $32.39 implies 23.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on ZLAB?
Current analyst recommendations:2 Strong Buy, 9 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 26, 2026, 02:04 AM

Technical Indicators

RSI (14-day)

70.36

Overbought

50-Day Moving Average

$20.77

26.00% above MA-50

200-Day Moving Average

$19.66

33.11% above MA-200

MACD Line

1.78

MACD Signal

1.63

MACD Histogram

0.15

Bullish

Q:What does ZLAB's RSI value tell investors?
The RSI (Relative Strength Index) for ZLAB is currently 70.36, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret ZLAB's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.78 above the signal line at 1.63, with histogram at 0.15. This bullish crossover suggests upward momentum is building. The 50-day MA ($20.77) is above the 200-day MA ($19.66), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Aug 26, 2026, 12:37 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$16.40
Created
Aug 13, 2026, 03:39 PM
Alert Condition
Price falls below
Threshold
$16.40
Created
Aug 13, 2026, 03:15 PM

Stay Ahead of the Market with Zai Lab Ltd Alerts

Set up price alerts for Zai Lab Ltd and get notified instantly when the price hits your target. Never miss an important price movement again.